A convenient and inexpensive chemo-radiosensitivity assay for lung cancer cells using Terasaki's microplate.

We devised a simple in vitro sensitivity test for lung cancer cells using Terasaki's microplate. We used the test to screen for sensitivity to various carcinostatic drugs and radiation, and to determine the optimum method of administration. This assay has been used in routine clinical examinations because about 40% of non-small cell carcinoma and 80% of small cell carcinoma of the lung can be subcultured. We describe here our patients who underwent treatment, various sensitivity tests and the preparation of an optimal course of treatment based upon the results of the sensitivity tests. Cells were placed in primary culture as previously described for short-term selective culture, and 2nd-3rd generation subcultured cells were transferred to individual wells of Terasaki's microplates for various sensitivity tests. After culture for 10 days, the effect was evaluated using 0.1% iodonitrotetrazolium (INT). This test permits a variety of sensitivity tests and various studies of clinical models of intensive treatment to be performed conveniently and reproducibly, because subcultured cancer cells are used. Another advantage is that these cells can be applied to basic investigations, including the preparation of monoclonal antibodies and chromosomes, DNA ploidy and oncogene studies.

[1]  T. Nakada,et al.  Culture and changes in dynamics of proliferation of pulmonary small cell carcinoma cells. , 1989, The Tohoku journal of experimental medicine.

[2]  [Surgical treatment of small cell carcinoma of the lung]. , 1987, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai.

[3]  T. Shields Surgery of small cell lung cancer. , 1986, Chest.

[4]  L. V. van Putten,et al.  Improvements and limitations of the subrenal capsule assay for determining tumour sensitivity to cytostatic drugs. , 1984, European journal of cancer & clinical oncology.

[5]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[6]  Venditti Jm The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary. , 1983 .

[7]  I. Tannock,et al.  A critical appraisal of the "human tumor stem-cell assay". , 1983, The New England journal of medicine.

[8]  M. Quinn,et al.  Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. , 1982, British Journal of Cancer.

[9]  H. Ichihashi,et al.  [In vitro tumor sensitivity tests to chemotherapeutic agents by the suppression of dehydrogenase activity]. , 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[10]  A. Bogdén,et al.  Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice. , 1979, Experimental cell biology.

[11]  A. Hamburger,et al.  Primary bioassay of human tumor stem cells. , 1977, Science.

[12]  G. Jacobsen,et al.  Chemotherapy of a human malignant melanoma transplanted in the nude mouse. , 1975, Cancer research.

[13]  J. H. Quastel,et al.  Biochemical studies of human tumors. II. In vitro estimation of individual tumor sensitivity to anticancer agents , 1966, Cancer.